您的购物车当前为空
NLRP3-IN-32(compound 7a)是一种3, 4-dihydronaphthalene-1(2H)-one衍生物,作为NLRP3炎症小体抑制剂,通过下调NLPR3和含有CARD的凋亡相关斑点样蛋白(ASC)的表达来阻止NLRP3炎症小体的组装与激活,并抑制活性氧(ROS)和其他炎症介质的产生。NLRP3-IN-32也通过抑制IκBα和NF-κB/p65的磷酸化及p65的核转位来减少NF-κB信号传导。
NLRP3-IN-32(compound 7a)是一种3, 4-dihydronaphthalene-1(2H)-one衍生物,作为NLRP3炎症小体抑制剂,通过下调NLPR3和含有CARD的凋亡相关斑点样蛋白(ASC)的表达来阻止NLRP3炎症小体的组装与激活,并抑制活性氧(ROS)和其他炎症介质的产生。NLRP3-IN-32也通过抑制IκBα和NF-κB/p65的磷酸化及p65的核转位来减少NF-κB信号传导。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
NLRP3-IN-32 相关产品
| 产品描述 | NLRP3-IN-32 (compound 7a) is a derivative of 3,4-dihydronaphthalene-1(2H)-one and acts as an inhibitor of the NLRP3 inflammasome. It obstructs the assembly and activation of the NLRP3 inflammasome by downregulating the expression of NLRP3 and the apoptosis-associated speck-like protein containing a CARD (ASC), thereby reducing the production of reactive oxygen species (ROS) and other inflammatory mediators. Additionally, NLRP3-IN-32 inhibits the phosphorylation of IκBα and NF-κB/p65, as well as the nuclear translocation of p65, thus suppressing NF-κB signaling. |
| 体外活性 | NLRP3-IN-32(compound 7a;1.5、3、6 μM)通过剂量依赖性方式逆转LPS刺激的RAW246.7巨噬细胞中炎症因子TNF-α、IL-6、IL-18和IL-1β的释放。该化合物在相同浓度下有效清除细胞内由LPS刺激产生的ROS和NO,并抑制NLRP3炎症小体的激活。NLRP3-IN-32对RAW246.7细胞表现出低毒性,不同剂量下细胞凋亡率分别为3.8%、5.6%和6.8%。此外,NLRP3-IN-32(1.5、3、6 μM;24小时)能够剂量依赖性地抑制LPS(1.0 μg/mL;2小时)刺激的IκBα磷酸化和p65磷酸化,进而抑制NF-κB信号通路的激活。 |
| 分子式 | C21H22BrN3O |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容